Bleeding complication due to accumulation of low-molecular-weight heparin in a patient with renal insufficiency

We report of a 71-year-old woman with a history of chronic analgesic nephropathy, who underwent coronary angiography. Because of anterior ventricular aneurysm, anticoagulation with nadroparine was installed. Continued ACE-inhibitor and ASA with additional intravenous contrast substance lead to acute...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Praxis (Bern. 1994) 2007-05, Vol.96 (18), p.733
Hauptverfasser: Schneiter, S, Huynh-Do, U, Heizmann, M
Format: Artikel
Sprache:ger
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 18
container_start_page 733
container_title Praxis (Bern. 1994)
container_volume 96
creator Schneiter, S
Huynh-Do, U
Heizmann, M
description We report of a 71-year-old woman with a history of chronic analgesic nephropathy, who underwent coronary angiography. Because of anterior ventricular aneurysm, anticoagulation with nadroparine was installed. Continued ACE-inhibitor and ASA with additional intravenous contrast substance lead to acute tubular necrosis with rapid decline of the renal function. Due to accumulation of the low molecular weight heparin, the patient developed an extensive retroperitoneal haematoma with circulatory shock and temporary anuric kidney failure. Low molecular weight heparins are commonly used during percutaneous coronary interventions. They are as safe and efficient compared to unfractioned heparin. But due to their renal elimination, they have to be monitored by measuring anti-factor Xa-activity if creatinine-clearance is
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_17520842</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17520842</sourcerecordid><originalsourceid>FETCH-LOGICAL-p542-ae106fa42a6072e94302dc5f9549c280c3066fe6fdefa71c6820196426cbf1173</originalsourceid><addsrcrecordid>eNo1z8tqwzAQBVAtWpo07S8U_YBAkiXZXrahLwhkk32YjEeximwJPwj5-xrSwsCFw-XC3LG1ck6JStlyxR7H8UdKZ2ptH9hKlVbLyug1S2-RqAn9mWPqcgwIU0g9b2biU-KAOHdzvFnyPKaL6FIkXGwQFwrnduItZRhCz5cDnpcu9RO_hKnlA_UQFx9n7wMujtcndu8hjvT8lxt2-Hg_bL_Ebv_5vX3diWyNFkBKOg9Gg5OlptoUUjdofW1NjbqSWEjnPDnfkIdSoau0VLUz2uHJK1UWG_Zym83zqaPmmIfQwXA9_j9e_AINUVV-</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Bleeding complication due to accumulation of low-molecular-weight heparin in a patient with renal insufficiency</title><source>Hogrefe eContent</source><source>MEDLINE</source><creator>Schneiter, S ; Huynh-Do, U ; Heizmann, M</creator><creatorcontrib>Schneiter, S ; Huynh-Do, U ; Heizmann, M</creatorcontrib><description>We report of a 71-year-old woman with a history of chronic analgesic nephropathy, who underwent coronary angiography. Because of anterior ventricular aneurysm, anticoagulation with nadroparine was installed. Continued ACE-inhibitor and ASA with additional intravenous contrast substance lead to acute tubular necrosis with rapid decline of the renal function. Due to accumulation of the low molecular weight heparin, the patient developed an extensive retroperitoneal haematoma with circulatory shock and temporary anuric kidney failure. Low molecular weight heparins are commonly used during percutaneous coronary interventions. They are as safe and efficient compared to unfractioned heparin. But due to their renal elimination, they have to be monitored by measuring anti-factor Xa-activity if creatinine-clearance is &lt;30 ml/min.</description><identifier>ISSN: 1661-8157</identifier><identifier>PMID: 17520842</identifier><language>ger</language><publisher>Switzerland</publisher><subject>Acute Kidney Injury - blood ; Acute Kidney Injury - chemically induced ; Acute Kidney Injury - therapy ; Acute Kidney Injury - urine ; Adolescent ; Age Factors ; Aged ; Anticoagulants - administration &amp; dosage ; Anticoagulants - adverse effects ; Anuria - chemically induced ; Child ; Creatinine - blood ; Creatinine - urine ; Enoxaparin - administration &amp; dosage ; Enoxaparin - adverse effects ; Enoxaparin - therapeutic use ; Factor Xa Inhibitors ; Female ; Glomerular Filtration Rate ; Hematoma - chemically induced ; Hematoma - drug therapy ; Humans ; Meta-Analysis as Topic ; Monitoring, Physiologic ; Nadroparin - administration &amp; dosage ; Nadroparin - adverse effects ; Randomized Controlled Trials as Topic ; Renal Dialysis ; Renal Insufficiency - blood ; Renal Insufficiency - complications ; Renal Insufficiency - urine ; Retroperitoneal Space ; Risk Factors ; Shock - chemically induced ; Time Factors ; Treatment Outcome</subject><ispartof>Praxis (Bern. 1994), 2007-05, Vol.96 (18), p.733</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17520842$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schneiter, S</creatorcontrib><creatorcontrib>Huynh-Do, U</creatorcontrib><creatorcontrib>Heizmann, M</creatorcontrib><title>Bleeding complication due to accumulation of low-molecular-weight heparin in a patient with renal insufficiency</title><title>Praxis (Bern. 1994)</title><addtitle>Praxis (Bern 1994)</addtitle><description>We report of a 71-year-old woman with a history of chronic analgesic nephropathy, who underwent coronary angiography. Because of anterior ventricular aneurysm, anticoagulation with nadroparine was installed. Continued ACE-inhibitor and ASA with additional intravenous contrast substance lead to acute tubular necrosis with rapid decline of the renal function. Due to accumulation of the low molecular weight heparin, the patient developed an extensive retroperitoneal haematoma with circulatory shock and temporary anuric kidney failure. Low molecular weight heparins are commonly used during percutaneous coronary interventions. They are as safe and efficient compared to unfractioned heparin. But due to their renal elimination, they have to be monitored by measuring anti-factor Xa-activity if creatinine-clearance is &lt;30 ml/min.</description><subject>Acute Kidney Injury - blood</subject><subject>Acute Kidney Injury - chemically induced</subject><subject>Acute Kidney Injury - therapy</subject><subject>Acute Kidney Injury - urine</subject><subject>Adolescent</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Anticoagulants - administration &amp; dosage</subject><subject>Anticoagulants - adverse effects</subject><subject>Anuria - chemically induced</subject><subject>Child</subject><subject>Creatinine - blood</subject><subject>Creatinine - urine</subject><subject>Enoxaparin - administration &amp; dosage</subject><subject>Enoxaparin - adverse effects</subject><subject>Enoxaparin - therapeutic use</subject><subject>Factor Xa Inhibitors</subject><subject>Female</subject><subject>Glomerular Filtration Rate</subject><subject>Hematoma - chemically induced</subject><subject>Hematoma - drug therapy</subject><subject>Humans</subject><subject>Meta-Analysis as Topic</subject><subject>Monitoring, Physiologic</subject><subject>Nadroparin - administration &amp; dosage</subject><subject>Nadroparin - adverse effects</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Renal Dialysis</subject><subject>Renal Insufficiency - blood</subject><subject>Renal Insufficiency - complications</subject><subject>Renal Insufficiency - urine</subject><subject>Retroperitoneal Space</subject><subject>Risk Factors</subject><subject>Shock - chemically induced</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>1661-8157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1z8tqwzAQBVAtWpo07S8U_YBAkiXZXrahLwhkk32YjEeximwJPwj5-xrSwsCFw-XC3LG1ck6JStlyxR7H8UdKZ2ptH9hKlVbLyug1S2-RqAn9mWPqcgwIU0g9b2biU-KAOHdzvFnyPKaL6FIkXGwQFwrnduItZRhCz5cDnpcu9RO_hKnlA_UQFx9n7wMujtcndu8hjvT8lxt2-Hg_bL_Ebv_5vX3diWyNFkBKOg9Gg5OlptoUUjdofW1NjbqSWEjnPDnfkIdSoau0VLUz2uHJK1UWG_Zym83zqaPmmIfQwXA9_j9e_AINUVV-</recordid><startdate>20070502</startdate><enddate>20070502</enddate><creator>Schneiter, S</creator><creator>Huynh-Do, U</creator><creator>Heizmann, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20070502</creationdate><title>Bleeding complication due to accumulation of low-molecular-weight heparin in a patient with renal insufficiency</title><author>Schneiter, S ; Huynh-Do, U ; Heizmann, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p542-ae106fa42a6072e94302dc5f9549c280c3066fe6fdefa71c6820196426cbf1173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2007</creationdate><topic>Acute Kidney Injury - blood</topic><topic>Acute Kidney Injury - chemically induced</topic><topic>Acute Kidney Injury - therapy</topic><topic>Acute Kidney Injury - urine</topic><topic>Adolescent</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Anticoagulants - administration &amp; dosage</topic><topic>Anticoagulants - adverse effects</topic><topic>Anuria - chemically induced</topic><topic>Child</topic><topic>Creatinine - blood</topic><topic>Creatinine - urine</topic><topic>Enoxaparin - administration &amp; dosage</topic><topic>Enoxaparin - adverse effects</topic><topic>Enoxaparin - therapeutic use</topic><topic>Factor Xa Inhibitors</topic><topic>Female</topic><topic>Glomerular Filtration Rate</topic><topic>Hematoma - chemically induced</topic><topic>Hematoma - drug therapy</topic><topic>Humans</topic><topic>Meta-Analysis as Topic</topic><topic>Monitoring, Physiologic</topic><topic>Nadroparin - administration &amp; dosage</topic><topic>Nadroparin - adverse effects</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Renal Dialysis</topic><topic>Renal Insufficiency - blood</topic><topic>Renal Insufficiency - complications</topic><topic>Renal Insufficiency - urine</topic><topic>Retroperitoneal Space</topic><topic>Risk Factors</topic><topic>Shock - chemically induced</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schneiter, S</creatorcontrib><creatorcontrib>Huynh-Do, U</creatorcontrib><creatorcontrib>Heizmann, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Praxis (Bern. 1994)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schneiter, S</au><au>Huynh-Do, U</au><au>Heizmann, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bleeding complication due to accumulation of low-molecular-weight heparin in a patient with renal insufficiency</atitle><jtitle>Praxis (Bern. 1994)</jtitle><addtitle>Praxis (Bern 1994)</addtitle><date>2007-05-02</date><risdate>2007</risdate><volume>96</volume><issue>18</issue><spage>733</spage><pages>733-</pages><issn>1661-8157</issn><abstract>We report of a 71-year-old woman with a history of chronic analgesic nephropathy, who underwent coronary angiography. Because of anterior ventricular aneurysm, anticoagulation with nadroparine was installed. Continued ACE-inhibitor and ASA with additional intravenous contrast substance lead to acute tubular necrosis with rapid decline of the renal function. Due to accumulation of the low molecular weight heparin, the patient developed an extensive retroperitoneal haematoma with circulatory shock and temporary anuric kidney failure. Low molecular weight heparins are commonly used during percutaneous coronary interventions. They are as safe and efficient compared to unfractioned heparin. But due to their renal elimination, they have to be monitored by measuring anti-factor Xa-activity if creatinine-clearance is &lt;30 ml/min.</abstract><cop>Switzerland</cop><pmid>17520842</pmid></addata></record>
fulltext fulltext
identifier ISSN: 1661-8157
ispartof Praxis (Bern. 1994), 2007-05, Vol.96 (18), p.733
issn 1661-8157
language ger
recordid cdi_pubmed_primary_17520842
source Hogrefe eContent; MEDLINE
subjects Acute Kidney Injury - blood
Acute Kidney Injury - chemically induced
Acute Kidney Injury - therapy
Acute Kidney Injury - urine
Adolescent
Age Factors
Aged
Anticoagulants - administration & dosage
Anticoagulants - adverse effects
Anuria - chemically induced
Child
Creatinine - blood
Creatinine - urine
Enoxaparin - administration & dosage
Enoxaparin - adverse effects
Enoxaparin - therapeutic use
Factor Xa Inhibitors
Female
Glomerular Filtration Rate
Hematoma - chemically induced
Hematoma - drug therapy
Humans
Meta-Analysis as Topic
Monitoring, Physiologic
Nadroparin - administration & dosage
Nadroparin - adverse effects
Randomized Controlled Trials as Topic
Renal Dialysis
Renal Insufficiency - blood
Renal Insufficiency - complications
Renal Insufficiency - urine
Retroperitoneal Space
Risk Factors
Shock - chemically induced
Time Factors
Treatment Outcome
title Bleeding complication due to accumulation of low-molecular-weight heparin in a patient with renal insufficiency
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-01T07%3A32%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bleeding%20complication%20due%20to%20accumulation%20of%20low-molecular-weight%20heparin%20in%20a%20patient%20with%20renal%20insufficiency&rft.jtitle=Praxis%20(Bern.%201994)&rft.au=Schneiter,%20S&rft.date=2007-05-02&rft.volume=96&rft.issue=18&rft.spage=733&rft.pages=733-&rft.issn=1661-8157&rft_id=info:doi/&rft_dat=%3Cpubmed%3E17520842%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/17520842&rfr_iscdi=true